Sorrento Therapeutics Inc (SRNE)

[dia76ca]

Here is one Dr. stressing need for monoclonal antibodies. COVI-DROPS could be the answer! Rapid delivery, low doses at a lower cost! Win, win, win!
"What people don't understand is that the protection you get from the vaccine seems so far to correlate with antibody titers (levels) achieved in the serum. These wane fairly quickly over time and so you depend on memory B cells to generate up antibody quickly when you are re-exposed to prevent serious illness. Some people aren't able to do that before becoming seriously ill. The monoclonal antibodies deliver a huge load of specific antibodies (far more than a body could ever make) that supercharge the serum. They are critical for high risk patients who have weaker immune systems (people over 60-65 and those with transplants and other diseases e.g. diabetes, obesity hypertension, etc). Monoclonals could save 10s of thousands if not hundred of thousands of lives in the US alone and take pressure off hospitals so other diseases can be treated. Monoclonal clinics should be the #1 national priority at this point. People that want the vaccine have already gotten it."